PMV Pharmaceuticals Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, PMV Pharmaceuticals Inc had 39.13M in cash and cash equivalents.

PMV Pharmaceuticals Inc reported 11.85M in total liabilities as of the latest reported quarter, including 11.41M in current liabilities and 435.00K in non-current liabilities.

As of the latest reported quarter, PMV Pharmaceuticals Inc's total assets were 116.56M, consisting of 115.23M in current assets and 1.33M in non-current assets.

PMV Pharmaceuticals Inc reported 104.71M in total shareholders' equity as of the latest reported quarter.